A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Clinical trial NCT00109330 · COMPLETED

Trial details

NCT number: NCT00109330
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Acellular Pertussis

Start date: 2002-11-01
Primary completion: 2004-04-01
Enrollment: 4116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.